DRUG Act

The DRUG Act, also known as Bill 118 hr 6283, is a piece of legislation currently being considered by the US Congress. The purpose of this bill is to address the issue of drug pricing and access to affordable medications for Americans.

The DRUG Act aims to increase transparency in the pharmaceutical industry by requiring drug manufacturers to disclose the costs associated with producing and marketing their medications. This information would then be made available to the public in order to promote greater understanding of drug pricing practices.

Additionally, the bill seeks to promote competition in the pharmaceutical market by allowing for the importation of lower-cost prescription drugs from other countries. This provision is intended to provide consumers with more affordable options for their medications and to help drive down prices in the US market. Furthermore, the DRUG Act includes measures to address the issue of drug shortages by requiring manufacturers to notify the Food and Drug Administration (FDA) of any potential disruptions in the supply chain. This information would then be used to help prevent shortages and ensure that patients have access to the medications they need. Overall, the DRUG Act is aimed at increasing transparency, promoting competition, and addressing drug shortages in order to improve access to affordable medications for all Americans. It is currently being debated in Congress and may undergo further revisions before being voted on.